Research and development structure for the third business area
First written in FY2020. 12 of 19 entries say "Restated". Latest entry: FY2026.
33 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「The main R&D activities during the consolidated fiscal year consisted of (1) improving existing products, (2) developing technologies for materials and construction methods without limiting the focus to calcium silicate, (3) developing new applications, and (4) conducting R&D aimed at developing a third business field.」
R&D on improving existing products, non-calcium-silicate materials and construction methods, new applications, a third business field and new environmentally oriented businesses was continued. R&D expense was ¥294.383 million. - 2026-05-13AdvancedManagement Plan
「産学協同研究のテーマをチャレンジ戦略枠を活⽤して拡⼤(2026年2月 1件採択)」
研究開発について、チャレンジ戦略枠を活用した産学協同研究の拡大を具体化した。 - FY2026-H1RestatedAnnual report
「The Group's R&D expense for the interim consolidated accounting period was 144,585. There were no significant changes in the status of R&D activities during the period.」
R&D expense of ¥144.585 million for the interim period was presented, with no significant changes in R&D activities. - FY2025AdvancedAnnual report
「The research results for the consolidated fiscal year under review are as follows.」
R&D expense increased to ¥202.648 million, and the Company made specific progress on new fireproofing licenses, construction methods for wood-based applications and logistics facilities, non-calcium-silicate building materials, and environmentally oriented businesses involving the effective use of waste. - FY2025-H1RestatedAnnual report
「There were no significant changes in the status of R&D activities during the interim consolidated cumulative period.」
The absence of significant changes in R&D activities was reconfirmed, and R&D expense of ¥90.609 million for the interim consolidated cumulative period was presented. - FY2024AdvancedAnnual report
「The main R&D activities during the consolidated fiscal year consisted of (1) improving existing products, (2) developing technologies for materials and construction methods without limiting the focus to calcium silicate, (3) developing new applications, and (4) conducting R&D aimed at developing a third business field.」
In addition to improving existing products, developing non-calcium-silicate materials and construction methods, developing new applications and developing a third business field, the Company advanced R&D into new environmentally oriented businesses involving the effective use of waste, and recorded R&D expense of ¥154.570 million. - FY2024-Q3RestatedAnnual report
「The Group's R&D expense for the cumulative period through the third quarter was ¥110.400 million. There were no significant changes in the status of R&D activities during the period.」
The absence of significant changes in R&D activities was reconfirmed, and R&D expense of ¥110.400 million for the cumulative period through the third quarter was presented. - FY2023AdvancedAnnual report
「R&D activities during the consolidated fiscal year consisted of (1) improving existing products, (2) developing technologies for materials and construction methods without limiting the focus to calcium silicate, (3) developing new applications, and (4) conducting R&D aimed at developing a third business field following the construction and plant sectors.」
R&D was conducted on improvements to existing products, non-calcium-silicate materials and construction methods, new applications and a third business field, and R&D expense of ¥142.333 million was recorded. - FY2023-Q3RestatedAnnual report
「The Group's R&D expense for the cumulative period through the third quarter was ¥110.181 million. There were no significant changes in the status of R&D activities during the period.」
The absence of material changes in research and development activities was reconfirmed, and research and development expenses for the nine-month period were disclosed. - FY2023-Q2RestatedAnnual report
「The Group's R&D expense for the cumulative period through the second quarter was ¥70.272 million. There were no significant changes in the status of R&D activities during the period.」
The R&D expense of ¥70.272 million for the cumulative period through the second quarter is presented, with no significant changes in R&D activities. - FY2023-Q1RestatedAnnual report
「The Group's R&D expense for the cumulative period through the first quarter was ¥34.688 million. There were no significant changes in the status of R&D activities during the period.」
The R&D expense of ¥34.688 million for the first quarter is presented, with no significant changes in R&D activities. - FY2022AdvancedAnnual report
「R&D activities during the consolidated fiscal year consisted of (1) advancing calcium silicate manufacturing technology, (2) developing new applications that leverage the properties of calcium silicate, and (3) developing technologies for low-cost materials without limiting the focus to calcium silicate.」
R&D was conducted on manufacturing technologies, new applications and low-cost materials, and R&D expense of ¥137.114 million was recorded. - FY2022-Q3RestatedAnnual report
「The Group's R&D expense for the cumulative period through the third quarter was ¥99.003 million. There were no significant changes in the status of R&D activities during the period.」
The R&D expense for the cumulative period through the third quarter is presented, with no significant changes in R&D activities. - FY2022-Q2RestatedAnnual report
「The group's research and development expenses for the six-month period were ¥63 million. There were no material changes in the status of research and development activities during the six-month period.」
The R&D expense for the cumulative period through the second quarter is presented, with no significant changes in R&D activities. - FY2022-Q1RestatedAnnual report
「There have been no material changes in the status of R&D activities during the cumulative first quarter of the current consolidated fiscal period.」
The absence of material changes in research and development activities was reconfirmed, and first-quarter research and development expenses of ¥27 million were disclosed. - FY2021ReframedAnnual report
「The research and development structure is based around the Technical Division, with collaboration among 4 divisions: the Building Business Division, Plant Business Division, Production Business Division and Technical Division.」
The description of the research and development structure changed from collaboration among 5 divisions centred on the former Product Technology Research Institute to collaboration among 4 divisions centred on the Technical Division. Research and development expenses were ¥148 million, and efforts are also being made in areas including low-cost materials and new environmentally focused businesses. - FY2021-Q3RestatedAnnual report
「The group's research and development expenses for the nine-month period were ¥107 million. There were no material changes in the status of research and development activities during the nine-month period.」
The absence of material changes in research and development activities was reconfirmed, and research and development expenses for the nine-month period were disclosed. - FY2021-Q2RestatedAnnual report
「The group's research and development expenses for the six-month period were ¥71 million. There were no material changes in the status of research and development activities during the six-month period.」
The absence of material changes in research and development activities was reconfirmed, and research and development expenses for the six-month period were disclosed. - FY2020First statedAnnual report
「The research and development structure is based around the Product Technology Research Institute, with collaboration among 5 divisions: the Building Business Division, Plant Business Division, Production Business Division, Product Technology Research Institute and Production Technology Research Institute.」
The collaboration structure among 5 divisions and research and development expenses of ¥172 million are disclosed.